This chapter explores the transformative potential of nanosystems for enhancing delivery mechanisms for biological therapeutics, which include proteins, peptides, antibodies, and nucleic acids. Despite the significant advantages of biologics in treating complex diseases, their clinical effectiveness is often limited by issues related to stability, targeted delivery, and controlled release. Nanotechnology offers sophisticated solutions to these challenges through the development of nanocarriers such as liposomes, lipid nanoparticles, dendrimers, polymeric nanoparticles, and metallic nanoparticles. These nanosystems are engineered to improve the stability, bioavailability, and precision targeting of biologicals, ensuring that these therapeutics reach their intended site of action efficiently while minimizing side effects. This chapter explores the design principles, mechanisms of action, and latest advancements in nanosystem technologies that facilitate active and passive targeting strategies to optimize therapeutic outcomes. Through detailed case studies and clinical applications, this discussion underscores the pivotal role of nanotechnology in advancing drug delivery systems, setting a foundation for future innovations in personalized medicine and targeted therapy.